ALICE: a randomized placebo-controlled phase II study...

ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer

Kyte, J. A., Røssevold, A., Falk, R. S., Naume, B.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Journal:
Journal of Translational Medicine
DOI:
10.1186/s12967-020-02424-7
Date:
December, 2020
File:
PDF, 902 KB
2020
Conversion to is in progress
Conversion to is failed